---
title: 'Manager, Quality Assurance at Rezolute'
canonical: 'https://feeny.ai/job/manager-quality-assurance-rezolute-redwood-city-ea9hyav4h4dr'
type: 'job'
last_seen: '2026-10-16'
---

# Manager, Quality Assurance at Rezolute

- **Company:** Rezolute
- **Location:** Redwood City, CA
- **Employment:** full-time
- **Work type:** onsite
- **Posted:** 2026-09-18
- **Last confirmed live:** 2026-10-16
- **Apply:** https://jobs.lever.co/rezolutebio/49abd24b-08c8-4662-b2d6-eb2acd744bf3

## Job description

Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our mission is to bring hope and meaningful solutions to patients and families affected by rare and difficult-to-treat diseases through scientific innovation, collaboration, and integrity. Rezolute’s lead investigational therapy, RZ358 (ersodetug), is a fully human monoclonal antibody in late-stage clinical development for the treatment of hypoglycemia due to congenital and acquired forms of hyperinsulinism (HI). As Rezolute expands its medical and scientific focus into tumor-related hyperinsulinism (tumor HI), most commonly related to pancreatic neuroendocrine tumors (insulinomas) or paraneoplastic hypoglycemia (NICTH), the company is committed to advancing novel therapeutic strategies that address this rare and complex form of hypoglycemia associated with insulin-secreting tumors and related neuro-oncology disorders More information can be found at rezolutebio.com

Position Description

The Manager, Quality Assurance at Rezolute is a dedicated Quality professional responsible for managing GxP quality requirements supporting product development, phase appropriate and proportionate lifecycle management of clinical products, and the commercialization, launch, and ongoing commercial supply of ersodetug. The Manager, Quality Assurance is a hands-on core member of the Quality team and plays a critical role across the product lifecycle from clinical development through post approval commercialization.

In partnership with other functional areas (including MSAT, Supply Chain, R&D, Regulatory Affairs, Pharmacovigilance, Sales, and Marketing), the Manager, Quality Assurance will develop and execute quality deliverables supporting CMC and commercial strategies, including the identification, assessment, and escalation of quality and compliance risks. This includes, but is not limited to, partnering with CMC and Commercial Operations to ensure that product is manufactured, released, distributed, promoted, and monitored in compliance with internal standards and applicable global regulatory requirements.

The Manager, Quality Assurance is a key contributor within Rezolute’s Quality organization and supports Quality Assurance processes for clinical stage programs, validation and qualification of commercial processes, product disposition, and post approval lifecycle management. This role also provides quality oversight for commercial activities, including support of sales and marketing materials, vendor and distributor oversight, product complaints investigations, and regulatory agency commitments following product approval.

Principle Duties and Responsibilities:

- Review and approval of Master Production Records from Contract Manufacturing Organizations to include Drug Substance manufacturing, Drug Product manufacturing, Finished Drug Product labeling and packaging operations, distribution of commercial product, and External Laboratory Oversight.
- Review of executed records and final Product Disposition of product intended for supply of clinical trials, extended access programs, and commercial supply.
- Provides the Quality oversight to ensure product is manufactured, tested, stored, and distributed according to cGMPs and other applicable regulations.
- Responsible for ensuring drug substance, drug product, and finished drug product, is dispositioned to meet Rezolute’s timelines, including labeling and packaging records.  Interacts with CMOs and Qualified Persons to ensure timely release of product in ex-US territories
- Attends, participates in, and contributes to CMC team meetings
- Provides Quality support for commercial packaging and distribution qualifications, validations, and operations including serialization.
- Reviews and/or approves methods, procedures, master records, executed records, reports and protocols employed in the conduct of cGMP activities
- Authors new or revisions to quality systems SOPs and work instructions to support quality functional activities.
- Reviews and approves production batch records, certificates of analysis, client notifications, specifications, qualifications, investigations, deviations, CAPA, certificates of origin, and certificates of conformance
- Provide Quality assessments and approvals for Change Controls impacting clinical or commercial products, processes, labeling, or distribution.
- Provide Quality review/approval of clinical and commercial Labeling & Artwork
- Provides technical quality and/or strategic support to sites during product service provider qualification audits, pre-approval inspections, and routine GMP inspections as required.
- Support post approval commitments, variations, and lifecycle management activities in collaboration with QA Compliance, Regulatory Affairs and CMC.
- Support Continuous Process Verification/Validation and ongoing commercial process monitoring activities.
- Contribute to inspection readiness activities and responses to regulatory agency questions, commitments, and post‑marketing requirements.

## Qualifications/Requirements

- Minimum of Bachelor’s degree in a scientific discipline with five to seven years’ experience in a cGMP regulated pharmaceutical/biotech environment
- Strong knowledge of appropriate Quality Systems and cGMPs (FDA, EU, ICH) with the ability to assess compliance risks
- Demonstrated ability to work independently and remotely, prioritize, problem-solve and complete activities in a timely manner without daily direction from the Head of Quality or others.
- Strong verbal skills, technical writing skills and ability to work with others in a collaborative manner.
- Ability to anticipate and mitigate challenges and apply a flexible risk-based approach to problem solving
- Experience with Microsoft Office is preferred

## Preferred Experience, Special Skills and Knowledge -

- Expertise and hands-on knowledge of GMPs
- Entrepreneurial, innovative, analytical, and solution-minded
- Proficiency in SharePoint, MS-Word, Excel, PowerPoint, Adobe Acrobat, and Veeva

Rezolute (RZLT) currently anticipates the base salary for the Manager of Quality Assurance  role could range from $140,000 to $165,000 and will depend in part on the successful candidate’s geographical location and their qualifications for the role, including education and experience. This position will also be eligible for an annual performance bonus in accordance with the terms of the applicable plan (depending, in part, on company and individual performance and at the Company’s discretion on an individual basis). The compensation described above is subject to change and could be higher or lower than the range described based on current market survey data and the qualifications, education, experience, and geographical location of the selected candidate.

Qualifying employees are eligible to participate in benefit programs such as:

Health Insurance (Medical / Dental / Vision) Disability, Life & Long-Term Care Insurance Holiday Pay Tracking Free Vacation Program 401(k) Plan Match Educational Assistance Benefit Fitness Center Reimbursement

We are an Equal Opportunity Employer and do not discriminate against applicants due to race, ethnicity, gender, veteran status, or on the basis of disability or any other federal, state or local protected class.

## About Rezolute

## Company Overview
- **One-liner**: Rezolute is a late-stage rare disease biotechnology company developing ersodetug, a monoclonal antibody therapy for hypoglycemia caused by congenital and tumor hyperinsulinism.
- **Entity Type**: Public (Nasdaq: RZLT)
- **Headquarters**: Redwood City, California, United States (with an additional office in Louisville)
- **Founded**: Not publicly available (IPO 2012)
- **Founders**: Not publicly available

## Core Business
- **Primary industry**: Biotechnology – rare disease therapeutics
- **Target customers**: B2B – healthcare providers, patients, and payers; focuses on addressing severe unmet medical needs in hyperinsulinism
- **Mission/purpose**: Significantly improve outcomes for individuals with hypoglycemia caused by hyperinsulinism ([rezolutebio.com – About](https://rezolutebio.com/job-openings/))

## Products & Services
- **Ersodetug (lead candidate)**: An intravenously administered human monoclonal antibody that allosterically binds to the insulin receptor, down‑modulating insulin action to restore normal glucose levels. Being developed for two indications:
  - **Congenital Hyperinsulinism (sunRIZE Phase 3 study)** – completed enrollment (May 2025) with 62 participants; topline results expected December 2025.
  - **Tumor Hyperinsulinism (upLIFT Phase 3 study)** – initiated mid‑2025; FDA agreed to a single‑arm open‑label design; topline results expected second half 2026.
  - Designations: Orphan Drug (US/EU), Rare Pediatric Disease, Breakthrough Therapy (US), PRIME (EU), ILAP (UK) ([ir.rezolutebio.com – 10-K](https://ir.rezolutebio.com/sec-filings/content/0001104659-25-090848/0001104659-25-090848.pdf))

## Market Standing
- **Valuation/Market Cap**: $317.7 million (as of recent data, per LinkedIn) ([linkedin.com](https://linkedin.com/company/rezolute))
- **Key Metric (Public)**: Annual revenue of $14.1 million (likely from grants or collaboration revenue; no product revenue yet) ([linkedin.com](https://linkedin.com/company/rezolute))
- **Notable Investors/Partners**: Not publicly available – company is publicly traded and does not disclose a lead investor list. Key partners include clinical trial sites and regulatory agencies (FDA, EMA).
- **Growth Signals**:
  - Headcount: 50 employees (+2.9% YoY) ([linkedin.com](https://linkedin.com/company/rezolute))
  - Phase 3 sunRIZE study fully enrolled; topline data pending December 2025.
  - Phase 3 upLIFT study enrolling with streamlined design; data expected second half 2026.
  - FDA granted Breakthrough Therapy Designation for tumor HI in May 2025.
  - Multiple regulatory designations accelerating development pathway.

## Competitive Advantages
- **Unique mechanism**: Ersodetug acts downstream from beta cells at the insulin receptor, allowing it to potentially treat all forms of hyperinsulinism (genetic or acquired) regardless of underlying cause.
- **Dosing convenience**: Half‑life >2 weeks enables monthly intravenous administration.
- **Regulatory momentum**: Orphan Drug, Rare Pediatric Disease, Breakthrough Therapy, PRIME, and ILAP designations provide expedited review, potential priority review voucher, and closer FDA/EMA collaboration.
- **Pivotal data catalysts**: Two Phase 3 studies read out within ~12‑18 months, creating clear value inflection points.

## Strategic Focus
- Execute the two ongoing Phase 3 trials (sunRIZE in congenital HI, upLIFT in tumor HI).
- Assuming positive topline data from sunRIZE, submit a Biologics License Application (BLA) to the FDA for ersodetug in mid‑2026.
- Continue to build commercial and medical affairs infrastructure (recent job postings indicate hires in Commercial Operations, Marketing, Payer Strategy, and Supply Chain) ([rezolutebio.com – Job Openings](https://rezolutebio.com/job-openings/)).

## Why Work Here
- **Mission‑driven**: Employees work on therapies for ultra‑rare, life‑threatening conditions with high unmet medical need.
- **Benefits**: Comprehensive health/dental/vision insurance, competitive salaries, annual bonus, 401(k) with company match, tuition assistance, on‑site meals, flexible spending accounts ([rezolutebio.com – Benefits](https://rezolutebio.com/job-openings/)).
- **Work environment**: Hybrid/office policy not explicitly stated; roles are based in Redwood City (HQ) and Louisville. Recent openings include remote-friendly functions? Not confirmed.
- **Growth opportunity**: Small company (~50 people) entering late‑stage development and pre‑commercial build‑out – employees can have broad impact and career advancement.
- **Engineering culture**: For biotech, the focus is on clinical operations, regulatory, and commercial roles rather than traditional engineering. IT positions (Business System Engineer) exist.

## Sources
1. [linkedin.com – Rezolute company page](https://linkedin.com/company/rezolute)
2. [rezolutebio.com – Job Openings & Benefits](https://rezolutebio.com/job-openings/)
3. [ir.rezolutebio.com – SEC 10-K Filing (September 2025)](https://ir.rezolutebio.com/sec-filings/content/0001104659-25-090848/0001104659-25-090848.pdf)
4. [rezolutebio.com – Leadership page](https://rezolutebio.com/leadership/)

## Other roles at Rezolute

- [Medical Writer II, Clinical/Regulatory](https://feeny.ai/job/medical-writer-ii-clinical-regulatory-rezolute-redwood-city-h43j74mshd1b) — Redwood City, CA
- [Executive & Administrative Business Partner](https://feeny.ai/job/executive-administrative-business-partner-rezolute-redwood-city-c1620sbmm02k) — Redwood City, CA
- [Director / Senior Director, Pharmacovigilance Operations](https://feeny.ai/job/director-senior-director-pharmacovigilance-operations-rezolute-remote-dnq13sn8dzh0)
- [Manager, Statistical Programming](https://feeny.ai/job/manager-statistical-programming-rezolute-remote-g58ra51zr042)
- [Sr. Medical Science Liaison](https://feeny.ai/job/sr-medical-science-liaison-rezolute-remote-p0q0xz8s2neg)
- [Senior Manager, External Supplier Operations](https://feeny.ai/job/senior-manager-external-supplier-operations-rezolute-redwood-city-pqxs0q5vsnyp) — Redwood City, CA
- [Sr Director, Regulatory Affairs](https://feeny.ai/job/sr-director-regulatory-affairs-rezolute-redwood-city-wqvf8n5fvptf) — Redwood City, CA
- [Head of Global Product Supply](https://feeny.ai/job/head-of-global-product-supply-rezolute-redwood-city-9yv4d2b9fg0s) — Redwood City, CA
- [Director Program Manager, Product Launch (Rare Disease)](https://feeny.ai/job/director-program-manager-product-launch-rare-disease-rezolute-redwood-city-vn56yjrm5v16) — Redwood City, CA
- [Sr. Director, Commercial Supply Chain](https://feeny.ai/job/sr-director-commercial-supply-chain-rezolute-redwood-city-e3ss6gz4cayw) — Redwood City, CA